rhodioloside has been researched along with 3-hydroxybutyric acid in 1 studies
| Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (3-hydroxybutyric acid) | Trials (3-hydroxybutyric acid) | Recent Studies (post-2010) (3-hydroxybutyric acid) |
|---|---|---|---|---|---|
| 621 | 2 | 519 | 4,646 | 422 | 1,992 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Dong, P; Jia, L; Jiang, M; Li, C; Liang, Q; Shi, H; Song, T; Wang, P | 1 |
1 other study(ies) available for rhodioloside and 3-hydroxybutyric acid
| Article | Year |
|---|---|
Salidroside simultaneously reduces de novo lipogenesis and cholesterol biosynthesis to attenuate atherosclerosis in mice.
Topics: 3-Hydroxybutyric Acid; Animals; Anticholesteremic Agents; Atherosclerosis; Cholesterol; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Glucose; Glucosides; Glycogen; Hypercholesterolemia; Lipidomics; Lipogenesis; Liver; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Phenols; Proton Magnetic Resonance Spectroscopy | 2021 |